Short Interest in Agilent Technologies Inc (NYSE:A) Decreases By 9.2%

Agilent Technologies Inc (NYSE:A) was the target of a large decrease in short interest in the month of December. As of December 31st, there was short interest totalling 4,660,000 shares, a decrease of 9.2% from the December 15th total of 5,130,000 shares. Based on an average daily trading volume, of 1,570,000 shares, the days-to-cover ratio is currently 3.0 days. Currently, 1.5% of the company’s stock are short sold.

Several equities analysts recently weighed in on A shares. UBS Group raised their price target on shares of Agilent Technologies from $82.00 to $87.00 and gave the company a “neutral” rating in a research report on Tuesday, November 26th. JPMorgan Chase & Co. boosted their price objective on Agilent Technologies from $85.00 to $90.00 and gave the stock an “overweight” rating in a report on Tuesday, November 26th. Stifel Nicolaus initiated coverage on Agilent Technologies in a research note on Thursday, November 14th. They issued a “hold” rating and a $85.00 price objective for the company. Needham & Company LLC started coverage on Agilent Technologies in a report on Friday, January 3rd. They issued a “buy” rating and a $77.00 target price on the stock. Finally, Citigroup initiated coverage on Agilent Technologies in a research report on Monday, January 6th. They set a “neutral” rating and a $85.00 target price on the stock. Seven investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Agilent Technologies currently has a consensus rating of “Buy” and an average price target of $84.57.

Shares of A stock opened at $87.99 on Wednesday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.21 and a current ratio of 1.53. The company has a market capitalization of $27.17 billion, a price-to-earnings ratio of 28.29, a PEG ratio of 2.05 and a beta of 1.42. Agilent Technologies has a 52-week low of $65.35 and a 52-week high of $88.32. The company has a 50-day simple moving average of $84.09 and a two-hundred day simple moving average of $76.29.

Agilent Technologies (NYSE:A) last posted its earnings results on Monday, November 25th. The medical research company reported $0.89 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.86 by $0.03. Agilent Technologies had a net margin of 20.74% and a return on equity of 20.13%. The firm had revenue of $1.37 billion for the quarter, compared to analysts’ expectations of $1.33 billion. During the same quarter last year, the firm earned $0.81 EPS. The company’s quarterly revenue was up 5.6% compared to the same quarter last year. On average, sell-side analysts forecast that Agilent Technologies will post 3.41 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st will be issued a dividend of $0.18 per share. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.16. This represents a $0.72 dividend on an annualized basis and a yield of 0.82%. The ex-dividend date is Monday, December 30th. Agilent Technologies’s dividend payout ratio (DPR) is 23.15%.

In other news, VP Mark Doak sold 8,016 shares of Agilent Technologies stock in a transaction dated Thursday, December 12th. The shares were sold at an average price of $84.50, for a total transaction of $677,352.00. Following the completion of the transaction, the vice president now directly owns 142,017 shares in the company, valued at $12,000,436.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Michael Tang sold 5,000 shares of the business’s stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $87.72, for a total transaction of $438,600.00. Following the sale, the senior vice president now directly owns 67,167 shares of the company’s stock, valued at $5,891,889.24. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 80,652 shares of company stock worth $6,657,846.

Hedge funds have recently bought and sold shares of the business. WealthStone Inc. purchased a new stake in shares of Agilent Technologies during the 2nd quarter valued at $31,000. Whittier Trust Co. of Nevada Inc. boosted its holdings in shares of Agilent Technologies by 185.5% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 471 shares of the medical research company’s stock worth $36,000 after buying an additional 306 shares during the last quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC bought a new position in Agilent Technologies during the second quarter valued at about $37,000. Doyle Wealth Management bought a new position in Agilent Technologies during the second quarter valued at about $37,000. Finally, NuWave Investment Management LLC increased its holdings in Agilent Technologies by 1,184.1% during the third quarter. NuWave Investment Management LLC now owns 565 shares of the medical research company’s stock worth $42,000 after buying an additional 521 shares during the last quarter.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

See Also: Monthly Dividend Stocks

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.